A randomized, double-blinded, placebo-controlled, crossover study of 5-aminolevulinic acid in the prevention of migraine
Not Applicable
- Conditions
- Migraine
- Registration Number
- JPRN-UMIN000019084
- Lead Sponsor
- Department of neurosurgery, Osaka Medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Individuals taking drugs or supplements influence to the migraine attacks. 2. Severe liver or renal impairment 3. Allergy to 5-aminolevulinic acid. 4. Severe systemic disorders, which need to medication. 5. Previous stroke or transient ischemic attack 6. Pregnancy or breastfeeding, including women trying to conceive 7. Porphyria and photosensitivity 8. History of alcohol or analgesic or psychotropic drug abuse 9. Those who already have entered another clinical trials.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method